Novakand Pharma AB (FRA:3EE0) OCF Yield %: -560.41 (As of Jul. 03, 2026)


What is Novakand Pharma AB OCF Yield %?

Novakand Pharma AB FRA:3EE0 OCF Yield % is -560.41 as of Jul. 03, 2026. The stock has 1 warning sign investors should review.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Novakand Pharma AB's Trailing 12-Month Cash Flow from Operations is €-2.76 Mil, and Market Cap is €0.01 Mil. Therefore, Novakand Pharma AB's OCF Yield % for today is -560.41%.

The historical rank and industry rank for Novakand Pharma AB's OCF Yield % or its related term are showing as below:

FRA:3EE0' s OCF Yield % Range Over the Past 10 Years
Min: -1232.68   Med: -20.29   Max: -2.54
Current: -560.41

During the past 13 years, the highest OCF Yield % of Novakand Pharma AB was -2.54%. The lowest was -1232.68%. And the median was -20.29%.

FRA:3EE0's OCF Yield % is not ranked
in the Biotechnology industry.
Industry Median: -8.155 vs FRA:3EE0: -560.41

Novakand Pharma AB's OCF Margin % for the quarter that ended in Dec. 2025 was %.

Novakand Pharma AB OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Novakand Pharma AB OCF Yield % Related Terms

Novakand Pharma AB OCF Yield % Historical Data

* Premium members only.

The historical data trend for Novakand Pharma AB's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novakand Pharma AB OCF Yield % Chart

Novakand Pharma AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.78 -29.46 -15.18 -57.44 -22,964.70

Novakand Pharma AB Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -45.38 -35.02 -19.30 -1,455.31 -18,781.05

FRA:3EE0 vs VRTX, REGN, ALNY: OCF Yield % Comparison

For the Biotechnology subindustry, Novakand Pharma AB's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novakand Pharma AB OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novakand Pharma AB's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Novakand Pharma AB's OCF Yield % falls into.


Novakand Pharma AB OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Novakand Pharma AB's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-2.783 / 0.0121186
=-22,964.70%

Novakand Pharma AB's annualized OCF Yield % for the quarter that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-0.569 * 4 / 0.0121186
=-18,781.05%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -560.41 mean?
Novakand Pharma AB (FRA:3EE0) has a OCF Yield % of -560.41 as of Jul. 03, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Novakand Pharma AB and its competitors.
Is Novakand Pharma AB's OCF Yield % too high?
Novakand Pharma AB's current OCF Yield % is -560.41.
How does Novakand Pharma AB's OCF Yield % compare to VRTX and REGN?
Novakand Pharma AB's OCF Yield % of -560.41 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Novakand Pharma AB and its competitors. Novakand Pharma AB's current OCF Yield % is -560.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novakand Pharma AB stock overvalued right now?
Novakand Pharma AB (FRA:3EE0) has a current OCF Yield % of -560.41. The current OCF Yield % is -560.41. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Novakand Pharma AB (FRA:3EE0), the current OCF Yield % is -560.41 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Novakand Pharma AB Business Description

Address Nanna Svarts vag 4, Solna, SWE, 171 65
Novakand Pharma AB is developing a new class of innovative drugs focusing on inflammatory diseases and cancer. The company is developing a new class of small molecule drugs that control disease promoting immune cells with precision, by targeting the fractalkine axis.